Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Sign Up to like & getrecommendations! Published in 2018 at "Pharmacoeconomics"
DOI: 10.1007/s40273-018-0646-1
Abstract: As part of the single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited Celgene Ltd to submit clinical and cost-effectiveness evidence for paclitaxel as albumin-bound nanoparticles (Nab-Pac) in combination… read more here.
Keywords: gem; nab pac; gem cap; pac gem ... See more keywords